Urban Health Today Editors

Urban Health Today

Data from a real-world <a href="https://pubmed.ncbi.nlm.nih.gov/34626863/">study</a> indicated that autologous stem cell transplantation (ASCT) should be offered to elderly patients with multiple myeloma (MM) pending pre-transplant evaluation. Patients treated with modern agents and transplant had about double the overall survival compared with patients without ASCT.&ldquo;We know that ASCT is safe and effective in older patients, but here we demonstrate a significant relative benefit in survival compared to patients in the same age range treated with novel agents alone without consolidative transplant,&rdquo; the study authors wrote.The retrospective single-center study looked at survival and safety outcomes in 53 patients with newly diagnosed MM aged 74 years or older. Patients were treated with high-dose therapy (HDT) and ASCT, then compared with 122 control patients of the same age that did not undergo transplant.The median age of the entire group was 77 years. There were no gender or race differences between the two groups. A higher proportion of patients with high-risk disease underwent ASCT.Almost all patients (93%) who underwent ASCT received triplet induction therapy with a proteasome inhibitor (PI) plus an immunomodulatory agent (IMID) backbone compared with about half (55%) of patients in the control group.Median progression-free survival for the ASCT group was 50 months compared with 30 months for the non-ASCT group. Median overall survival was nearly doubled among patients who underwent ASCT (79.67 months vs. 39.79 months).In patients with high-risk disease, the median progression-free survival was 60.8 months and the median overall survival was 77.8 months in the ASCT group, compared with 26 and 38 months, respectively, in the control group.The researchers noted that one important limitation of the study is that patients were not matched for age or performance status, which limits the ability to draw definitive conclusions.

Payton White, BS

How Sleep Quality Influences Risk of Alzheimer’s Disease

Alzheimer's & Dementia

Lou Portero

Hidden Dangers: The Blood Sugar Crisis in Modern Breast Cancer Treatment

Diabetes in Women

New ACG Guidelines Address Critical Gastric Cancer Disparities in Non-White Americans

Gastroenterology

Latest News

Undergoing ASCT Nearly Doubled Survival in Elderly Patients With Multiple Myeloma

Multiple Myeloma

Data from a real-world study indicated that autologous stem cell transplantation (ASCT) should be offered to elderly ...

About Us

Editorial Policy

Contributors & Partners

Contact Us

eNewsletters

Work With Us

Advertising

Career Center

GU Oncology Now

Blood Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Food Allergy Roundtable Discussions

Allergy

Blood Cancers

— Multiple Myeloma

Breast Cancer

Colorectal Cancer

Pancreatic Cancer

Prostate Cancer

Cancer

Diabetes

Heart Failure

Heart Disease Prevention

Heart Health

— Alzheimer’s Disease

Neurology

Public Health

Autoimmune Disease

Infectious Diseases

Obesity

Pediatrics

Sickle Cell Disease

Digital Health

Dermatology

Pulmonology

Video Insights

Workforce News

More

Gynecologic Cancer

Heart Disease in Women

Menopause

Reproductive Health

Women’s Neurology

Well Woman Today

Roundtables

Podcasts

Conferences

Viewpoints

Subscribe